Hrönn Harðardóttir

2.0k total citations
11 papers, 94 citations indexed

About

Hrönn Harðardóttir is a scholar working on Oncology, Infectious Diseases and Neurology. According to data from OpenAlex, Hrönn Harðardóttir has authored 11 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Infectious Diseases and 4 papers in Neurology. Recurrent topics in Hrönn Harðardóttir's work include COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and COVID-19 and Mental Health (2 papers). Hrönn Harðardóttir is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and COVID-19 and Mental Health (2 papers). Hrönn Harðardóttir collaborates with scholars based in Iceland, Sweden and United States. Hrönn Harðardóttir's co-authors include Tómas Guðbjartsson, Steinn Jónsson, Unnur Valdimarsdóttir, Pétur Hannesson, Sif Hansdóttir, Ingibjörg Jóna Guðmundsdóttir, Bylgja Hilmarsdóttir, Haiying Cheng, Fang Fang and Huan Song and has published in prestigious journals such as Cancer Epidemiology Biomarkers & Prevention, Supportive Care in Cancer and Acta Oncologica.

In The Last Decade

Hrönn Harðardóttir

8 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hrönn Harðardóttir Iceland 6 45 31 30 19 17 11 94
Razi Alalqam Ireland 3 11 0.2× 13 0.4× 16 0.5× 31 1.6× 37 2.2× 4 129
Antoinette Schouten‐van Meeteren Netherlands 5 13 0.3× 14 0.5× 15 0.5× 40 2.1× 23 1.4× 5 161
Reut Riff Israel 6 19 0.4× 19 0.6× 7 0.2× 25 1.3× 7 0.4× 8 102
M. Maspoli-Conconi Switzerland 4 44 1.0× 24 0.8× 36 1.2× 4 0.2× 8 0.5× 6 67
John Eppensteiner United States 2 6 0.1× 22 0.7× 19 0.6× 23 1.2× 6 0.4× 5 95
Dana Sochorová Czechia 6 25 0.6× 6 0.2× 9 0.3× 16 0.8× 12 0.7× 14 123
Remy Merkx Netherlands 6 24 0.5× 59 1.9× 18 0.6× 23 1.2× 4 0.2× 8 171
Luca Tagliafico Italy 5 15 0.3× 7 0.2× 15 0.5× 23 1.2× 11 0.6× 19 88
Gabriella Gislimberti Italy 3 32 0.7× 18 0.6× 10 0.3× 12 0.6× 9 0.5× 3 51
Aurélie Parzy France 4 39 0.9× 59 1.9× 10 0.3× 11 0.6× 2 0.1× 15 99

Countries citing papers authored by Hrönn Harðardóttir

Since Specialization
Citations

This map shows the geographic impact of Hrönn Harðardóttir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hrönn Harðardóttir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hrönn Harðardóttir more than expected).

Fields of papers citing papers by Hrönn Harðardóttir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hrönn Harðardóttir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hrönn Harðardóttir. The network helps show where Hrönn Harðardóttir may publish in the future.

Co-authorship network of co-authors of Hrönn Harðardóttir

This figure shows the co-authorship network connecting the top 25 collaborators of Hrönn Harðardóttir. A scholar is included among the top collaborators of Hrönn Harðardóttir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hrönn Harðardóttir. Hrönn Harðardóttir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Harðardóttir, Hrönn, Thor Aspelund, Katja Fall, et al.. (2023). Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden. Acta Oncologica. 62(10). 1338–1347.
2.
Axelsson, G., et al.. (2022). Respiratory function and CT abnormalities among survivors of COVID-19 pneumonia: a nationwide follow-up study. BMJ Open Respiratory Research. 9(1). e001347–e001347. 3 indexed citations
3.
Axelsson, G., et al.. (2021). Parenchymal lung changes on CT in patients with coronavirus disease 2019 (COVID-19). Læknablaðið. 107(10). 460–468.
4.
Harðardóttir, Hrönn, Thor Aspelund, Jianwei Zhu, et al.. (2021). Optimal communication associated with lower risk of acute traumatic stress after lung cancer diagnosis. Supportive Care in Cancer. 30(1). 259–269. 5 indexed citations
5.
Harðardóttir, Hrönn, et al.. (2021). Delirium and fever – a rare but dangerous cause Case report. Læknablaðið. 107(708). 345–349.
6.
Harðardóttir, Hrönn, Steinn Jónsson, Bylgja Hilmarsdóttir, et al.. (2021). Advances in lung cancer diagnosis and treatment - a review. Læknablaðið. 108(1). 17–29. 29 indexed citations
7.
Axelsson, G., Elías Eyþórsson, Hrönn Harðardóttir, Gunnar Guðmundsson, & Sif Hansdóttir. (2020). The impact of lung diseases, smoking and e-cigarette use on the severity of COVID-19 illness at diagnosis. Læknablaðið. 106(12). 574–579. 3 indexed citations
8.
Ísaksson, Helgi J., et al.. (2019). Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study. General Thoracic and Cardiovascular Surgery. 68(5). 523–529. 17 indexed citations
9.
Udumyan, Ruzan, Scott Montgomery, Fang Fang, et al.. (2019). Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non–Small Cell Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 29(1). 119–126. 11 indexed citations
10.
Deng, Lei, Hrönn Harðardóttir, Huan Song, et al.. (2019). Mortality of lung cancer as a second primary malignancy: A population‐based cohort study. Cancer Medicine. 8(6). 3269–3277. 19 indexed citations
11.
Guðbjartsson, Tómas, Halla Skúladóttir, Hrönn Harðardóttir, et al.. (2008). [Lung cancer--review].. PubMed. 94(4). 297–311. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Razi Alalqam Breakdown of academic impact, for papers by Antoinette Schouten‐van Meeteren Breakdown of academic impact, for papers by Reut Riff Breakdown of academic impact, for papers by M. Maspoli-Conconi Breakdown of academic impact, for papers by John Eppensteiner Breakdown of academic impact, for papers by Dana Sochorová Breakdown of academic impact, for papers by Remy Merkx Breakdown of academic impact, for papers by Luca Tagliafico Breakdown of academic impact, for papers by Gabriella Gislimberti Breakdown of academic impact, for papers by Aurélie Parzy
Rankless by CCL
2026